Sleeping pills and cancer | Home | Sepracor announces results of Phase IV study of drug for insomnia treatment

September 2, 2008

Somaxon Presents Pharmacological Data on Doxepin at the 21st European …

Somaxon Pharmaceuticals, Inc. , a specialty pharmaceutical company focused on the in-licensing and development of proprietary product candidates for the treatment of diseases and disorders in the fields of …


From Insomnia News

This entry was posted on Tuesday, September 2nd, 2008 at 9:34 pm and is filed under Insomnia. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

Comments are closed.